{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:13:43Z","timestamp":1792491223230,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-037-011-"],"award-info":[{"award-number":["MOST 111-2314-B-037-011-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-037-020-"],"award-info":[{"award-number":["MOST 111-2314-B-037-020-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-037-046-"],"award-info":[{"award-number":["MOST 111-2314-B-037-046-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["IDS2B"],"award-info":[{"award-number":["IDS2B"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH110-0R43"],"award-info":[{"award-number":["KMUH110-0R43"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH110-0M65"],"award-info":[{"award-number":["KMUH110-0M65"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH111-1M56"],"award-info":[{"award-number":["KMUH111-1M56"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH111-1R37"],"award-info":[{"award-number":["KMUH111-1R37"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH-DK(A)112001"],"award-info":[{"award-number":["KMUH-DK(A)112001"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-DK(A)112006"],"award-info":[{"award-number":["KMU-DK(A)112006"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["NYCU-KMU-112-I005"],"award-info":[{"award-number":["NYCU-KMU-112-I005"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interleukin-1 receptor antagonist (IL-1RA), a member of the IL-1 family, has diverse roles in cancer development. However, the role of IL-1RA in oral squamous cell carcinoma (OSCC), in particular the underlying mechanisms, remains to be elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Tumor tissues from OSCC patients were assessed for protein expression by immunohistochemistry. Patient survival was evaluated by Kaplan\u2013Meier curve analysis. Impact of differential IL-1RA expression on cultured OSCC cell lines was assessed in vitro by clonogenic survival, tumorsphere formation, soft agar colony formation, and transwell cell migration and invasion assays. Oxygen consumption rate was measured by Seahorse analyzer or multi-mode plate reader. PCR array was applied to screen human cancer stem cell-related genes, proteome array for phosphorylation status of kinases, and Western blot for protein expression in cultured cells. In vivo tumor growth was investigated by orthotopic xenograft in mice, and protein expression in xenograft tumors assessed by immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical analysis revealed that elevated IL-1RA expression in OSCC tumor tissues was associated with increased tumor size and cancer stage, and reduced survival in the patient group receiving adjuvant radiotherapy compared to the patient group without adjuvant radiotherapy. In vitro data supported these observations, showing that overexpression of IL-1RA increased OSCC cell growth, migration\/invasion abilities, and resistance to ionizing radiation, whereas knockdown of IL-1RA had largely the opposite effects. Additionally, we identified that EGFR\/JNK activation and SOX2 expression were modulated by differential IL-1RA expression downstream of mitochondrial metabolism, with application of mitochondrial complex inhibitors suppressing these pathways. Furthermore, in vivo data revealed that treatment with cisplatin or metformin\u2014a mitochondrial complex inhibitor and conventional therapy for type 2 diabetes\u2014reduced IL-1RA-associated xenograft tumor growth as well as EGFR\/JNK activation and SOX2 expression. This inhibitory effect was further augmented by combination treatment with cisplatin and metformin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The current study suggests that IL-1RA promoted OSCC malignancy through mitochondrial metabolism-mediated EGFR\/JNK activation and SOX2 expression. Inhibition of this mitochondrial metabolic pathway may present a potential therapeutic strategy in OSCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04343-9","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T02:02:25Z","timestamp":1689559345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR\/JNK\/SOX2 pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Shyng-Shiou F.","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leong-Perng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos C.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hieu D. H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk-Kwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Chu\u2010Sung","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4442-4801","authenticated-orcid":false,"given":"Yen-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"issue":"2","key":"4343_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0022034519894963","volume":"99","author":"M Du","year":"2020","unstructured":"Du M, Nair R, Jamieson L, Liu Z, Bi P. Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990\u20132017. J Dent Res. 2020;99(2):143\u201351.","journal-title":"J Dent Res"},{"issue":"9","key":"4343_CR2","first-page":"11884","volume":"8","author":"C Rivera","year":"2015","unstructured":"Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884\u201394.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"4343_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4343_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/froh.2020.00003","volume":"1","author":"RD Coletta","year":"2020","unstructured":"Coletta RD, Yeudall WA, Salo T. Grand challenges in oral cancers. Front Oral Health. 2020;1:3.","journal-title":"Front Oral Health"},{"key":"4343_CR5","doi-asserted-by":"publisher","first-page":"761379","DOI":"10.3389\/fonc.2021.761379","volume":"11","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Li S, Gao L, Zhi K, Ren W. The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma. Front Oncol. 2021;11:761379.","journal-title":"Front Oncol"},{"issue":"9","key":"4343_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/jop.12306","volume":"44","author":"N Vig","year":"2015","unstructured":"Vig N, Mackenzie IC, Biddle A. Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma. J Oral Pathol Med. 2015;44(9):649\u201355.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"4343_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","volume":"16","author":"SY Lee","year":"2017","unstructured":"Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer. 2017;16(1):10.","journal-title":"Mol Cancer"},{"issue":"1","key":"4343_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41368-020-00087-0","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang M, Luo J, Zhou H. Radiotherapy targeting cancer stem cells \u201cawakens\u201d them to induce tumour relapse and metastasis in oral cancer. Int J Oral Sci. 2020;12(1):19.","journal-title":"Int J Oral Sci"},{"issue":"13","key":"4343_CR9","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.3390\/cancers13133311","volume":"13","author":"H Moindjie","year":"2021","unstructured":"Moindjie H, Rodrigues-Ferreira S, Nahmias C. Mitochondrial metabolism in carcinogenesis and cancer therapy. Cancers. 2021;13(13):3311.","journal-title":"Cancers"},{"issue":"3","key":"4343_CR10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.18632\/aging.101822","volume":"11","author":"F Sotgia","year":"2019","unstructured":"Sotgia F, Fiorillo M, Lisanti MP. Hallmarks of the cancer cell of origin: comparisons with \u201cenergetic\u201d cancer stem cells (e-CSCs). Aging. 2019;11(3):1065\u20138.","journal-title":"Aging"},{"key":"4343_CR11","first-page":"21","volume":"941","author":"AS Yazdi","year":"2021","unstructured":"Yazdi AS, Ghoreschi K. The interleukin-1 family. Regul Cytokine Gene Expr Immun Dis. 2021;941:21\u20139.","journal-title":"Regul Cytokine Gene Expr Immun Dis"},{"key":"4343_CR12","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s11095-013-1118-0","volume":"30","author":"MS Akash","year":"2013","unstructured":"Akash MS, Rehman K, Chen S. IL-1Ra and its delivery strategies: inserting the association in perspective. Pharmaceut Res. 2013;30:2951\u201366.","journal-title":"Pharmaceut Res"},{"issue":"5\u20136","key":"4343_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/08830189809043005","volume":"16","author":"CA Dinarello","year":"1998","unstructured":"Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 1998;16(5\u20136):457\u201399.","journal-title":"Int Rev Immunol"},{"issue":"6256","key":"4343_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/343341a0","volume":"343","author":"SP Eisenberg","year":"1990","unstructured":"Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990;343(6256):341\u20136.","journal-title":"Nature"},{"issue":"6","key":"4343_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/00365529709025103","volume":"32","author":"H Iwagaki","year":"1997","unstructured":"Iwagaki H, Hizuta A, Tanaka N. Interleukin-1 receptor antagonists and other markers in colorectal cancer patients. Scand J Gastroenterol. 1997;32(6):577\u201381.","journal-title":"Scand J Gastroenterol"},{"issue":"9\u201310","key":"4343_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0753-3322(01)00140-8","volume":"55","author":"R Kurzrock","year":"2001","unstructured":"Kurzrock R. Cytokine deregulation in cancer. Biomed Pharmacother. 2001;55(9\u201310):543\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"4343_CR17","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1158\/1055-9965.EPI-07-0302","volume":"16","author":"DJ Parekh","year":"2007","unstructured":"Parekh DJ, Ankerst DP, Baillargeon J, Higgins B, Platz EA, Troyer D, Hernandez J, Leach RJ, Lokshin A, Thompson IM. Assessment of 54 biomarkers for biopsy-detectable prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(10):1966\u201372.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"4343_CR18","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3892\/ijo.2015.2917","volume":"46","author":"M Shiiba","year":"2015","unstructured":"Shiiba M, Saito K, Yamagami H, Nakashima D, Higo M, Kasamatsu A, Sakamoto Y, Ogawara K, Uzawa K, Takiguchi Y, Tanzawa H. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies. Int J Oncol. 2015;46(5):1978\u201384.","journal-title":"Int J Oncol"},{"issue":"1","key":"4343_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0090-8258(02)00154-3","volume":"89","author":"R Fujiwaki","year":"2003","unstructured":"Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Hata K, Katabuchi H, Okamura H, Miyazaki K. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecol Oncol. 2003;89(1):77\u201383.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4343_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0304-3835(99)00162-7","volume":"142","author":"N Iizuka","year":"1999","unstructured":"Iizuka N, Hazama S, Hirose K, Abe T, Tokuda N, Fukumoto T, Tangoku A, Oka M. Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma. Cancer Lett. 1999;142(2):179\u201384.","journal-title":"Cancer Lett"},{"key":"4343_CR21","doi-asserted-by":"publisher","first-page":"722676","DOI":"10.3389\/froh.2021.722676","volume":"2","author":"SE Niklander","year":"2021","unstructured":"Niklander SE, Murdoch C, Hunter KD. IL-1\/IL-1R signaling in head and neck cancer. Front oral health. 2021;2:722676.","journal-title":"Front oral health"},{"key":"4343_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.canlet.2020.04.025","volume":"485","author":"YF Yang","year":"2020","unstructured":"Yang YF, Wang YY, Hsiao M, Lo S, Chang YC, Jan YH, Lai TC, Lee YC, Hsieh YC, Yuan SF. IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway. Cancer Lett. 2020;485:27\u201337.","journal-title":"Cancer Lett"},{"key":"4343_CR23","first-page":"2019","volume":"353\u2013363","author":"J Zhang","year":"1928","unstructured":"Zhang J, Zhang Q. Using Seahorse machine to measure OCR and ECAR in cancer cells. Methods Mol Biol. 1928;353\u2013363:2019.","journal-title":"Methods Mol Biol"},{"issue":"20","key":"4343_CR24","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1038\/s41388-021-01698-5","volume":"40","author":"YY Wang","year":"2021","unstructured":"Wang YY, Chen YK, Lo S, Chi TC, Chen YH, Hu SC, Chen YW, Jiang SS, Tsai FY, Liu W, Li RN, Hsieh YC, Huang CJ, Yuan SF. MRE11 promotes oral cancer progression through RUNX2\/CXCR4\/AKT\/FOXA2 signaling in a nuclease-independent manner. Oncogene. 2021;40(20):3510\u201332.","journal-title":"Oncogene"},{"issue":"12","key":"4343_CR25","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.3390\/cancers12123526","volume":"12","author":"YY Wang","year":"2020","unstructured":"Wang YY, Chen HD, Lo S, Chen YK, Huang YC, Hu SC, Hsieh YC, Hung AC, Hou MF, Yuan SF. Visfatin enhances breast cancer progression through CXCL1 induction in tumor-associated macrophages. Cancers. 2020;12(12):3526.","journal-title":"Cancers"},{"issue":"1","key":"4343_CR26","doi-asserted-by":"publisher","first-page":"15437","DOI":"10.1038\/s41598-022-19290-6","volume":"12","author":"YY Wang","year":"2022","unstructured":"Wang YY, Hung AC, Wu YC, Lo S, Chen HD, Chen YK, Hsieh YC, Hu SC, Hou MF, Yuan SF. ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model. Sci Rep. 2022;12(1):15437.","journal-title":"Sci Rep"},{"issue":"5","key":"4343_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/jpm12050841","volume":"12","author":"SF Yuan","year":"2022","unstructured":"Yuan SF, Hung AC, Hsu CW, Lan TH, Su CW, Chi TC, Chang YC, Chen YK, Wang YY. CD44 mediates oral squamous cell carcinoma-promoting activity of MRE11 via AKT signaling. J Pers Med. 2022;12(5):841.","journal-title":"J Pers Med"},{"issue":"6859","key":"4343_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105\u201311.","journal-title":"Nature"},{"key":"4343_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fonc.2018.00347","volume":"8","author":"HF Bahmad","year":"2018","unstructured":"Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, El-Hajj A, Mukherji D, Liu YN, Daoud G, Abou-Kheir W. Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem\/progenitor sphere-forming cells. Front Oncol. 2018;8:347.","journal-title":"Front Oncol"},{"issue":"6","key":"4343_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/bjc.1982.297","volume":"46","author":"MV Agrez","year":"1982","unstructured":"Agrez MV, Kovach JS, Lieber MM. Cell aggregates in the soft agar \u201chuman tumour stem-cell assay.\u201d Br J Cancer. 1982;46(6):880\u20137.","journal-title":"Br J Cancer"},{"issue":"11","key":"4343_CR31","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1038\/s41596-021-00615-0","volume":"16","author":"N Brix","year":"2021","unstructured":"Brix N, Samaga D, Belka C, Zitzelsberger H, Lauber K. Analysis of clonogenic growth in vitro. Nat Protoc. 2021;16(11):4963\u201391.","journal-title":"Nat Protoc"},{"issue":"1","key":"4343_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald LB, Bellet D, Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia. 2015;17(1):1\u201315.","journal-title":"Neoplasia"},{"issue":"7239","key":"4343_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780\u20133.","journal-title":"Nature"},{"issue":"10","key":"4343_CR34","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/fj.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti P, Fovez Q, Germain N, Khamari R, Kluza J. Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells. FASEB J. 2020;34(10):13106\u201324.","journal-title":"FASEB J"},{"issue":"4","key":"4343_CR35","doi-asserted-by":"publisher","first-page":"101140","DOI":"10.1016\/j.jbc.2021.101140","volume":"297","author":"CA Schmidt","year":"2021","unstructured":"Schmidt CA, Fisher-Wellman KH, Neufer PD. From OCR and ECAR to energy: perspectives on the design and interpretation of bioenergetics studies. J Biol Chem. 2021;297(4):101140.","journal-title":"J Biol Chem"},{"issue":"12","key":"4343_CR36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1089\/ars.2009.2743","volume":"12","author":"WJ Koopman","year":"2010","unstructured":"Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, Willems PH. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal. 2010;12(12):1431\u201370.","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"4343_CR37","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bbabio.2015.11.009","volume":"1857","author":"M Murai","year":"2016","unstructured":"Murai M, Miyoshi H. Current topics on inhibitors of respiratory complex I. Biochim Biophys Acta. 2016;1857(7):884\u201391.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"4343_CR38","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1158\/1078-0432.CCR-06-0646","volume":"12","author":"M Ono","year":"2006","unstructured":"Ono M, Kuwano M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res. 2006;12(24):7242\u201351.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"4343_CR39","doi-asserted-by":"publisher","first-page":"15410","DOI":"10.3390\/ijms232315410","volume":"23","author":"BN Forgie","year":"2022","unstructured":"Forgie BN, Prakash R, Telleria CM. Revisiting the anti-cancer toxicity of clinically approved platinating derivatives. Int J Mol Sci. 2022;23(23):15410.","journal-title":"Int J Mol Sci"},{"key":"4343_CR40","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.258932","author":"N Andres-Sanchez","year":"2022","unstructured":"Andres-Sanchez N, Fisher D, Krasinska L. Physiological functions and roles in cancer of the proliferation marker Ki-67. J Cell Sci. 2022. https:\/\/doi.org\/10.1242\/jcs.258932.","journal-title":"J Cell Sci"},{"key":"4343_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.09.004","volume":"62","author":"B Boersma","year":"2021","unstructured":"Boersma B, Jiskoot W, Lowe P, Bourquin C. The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. Cytokine Growth Factor Rev. 2021;62:1\u201314.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"4343_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imr.12614","volume":"281","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Barajon I, Garlanda C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 2018;281(1):57\u201361.","journal-title":"Immunol Rev"},{"issue":"1","key":"4343_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund S, Avanzato D, Lanzetti L. Emerging functions of the EGFR in cancer. Mol Oncol. 2018;12(1):3\u201320.","journal-title":"Mol Oncol"},{"issue":"1","key":"4343_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","volume":"24","author":"A Tomas","year":"2014","unstructured":"Tomas A, Futter CE, Eden ER. EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol. 2014;24(1):26\u201334.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4343_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2045-3701-2-13","volume":"2","author":"YN Wang","year":"2012","unstructured":"Wang YN, Hung MC. Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family. Cell Biosci. 2012;2(1):13.","journal-title":"Cell Biosci"},{"issue":"16","key":"4343_CR46","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1128\/MCB.24.16.7059-7071.2004","volume":"24","author":"JL Boerner","year":"2004","unstructured":"Boerner JL, Demory ML, Silva C, Parsons SJ. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol. 2004;24(16):7059\u201371.","journal-title":"Mol Cell Biol"},{"issue":"52","key":"4343_CR47","doi-asserted-by":"publisher","first-page":"36592","DOI":"10.1074\/jbc.M109.000760","volume":"284","author":"ML Demory","year":"2009","unstructured":"Demory ML, Boerner JL, Davidson R, Faust W, Miyake T, Lee I, Huttemann M, Douglas R, Haddad G, Parsons SJ. Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J Biol Chem. 2009;284(52):36592\u2013604.","journal-title":"J Biol Chem"},{"issue":"35","key":"4343_CR48","doi-asserted-by":"publisher","first-page":"37349","DOI":"10.18632\/oncotarget.5736","volume":"6","author":"TF Che","year":"2015","unstructured":"Che TF, Lin CW, Wu YY, Chen YJ, Han CL, Chang YL, Wu CT, Hsiao TH, Hong TM, Yang PC. Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC. Oncotarget. 2015;6(35):37349\u201366.","journal-title":"Oncotarget"},{"issue":"23","key":"4343_CR49","doi-asserted-by":"publisher","first-page":"20558","DOI":"10.1074\/jbc.M111.240796","volume":"286","author":"WC Huang","year":"2011","unstructured":"Huang WC, Chen YJ, Li LY, Wei YL, Hsu SC, Tsai SL, Chiu PC, Huang WP, Wang YN, Chen CH, Chang WC, Chang WC, Chen AJ, Tsai CH, Hung MC. Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells. J Biol Chem. 2011;286(23):20558\u201368.","journal-title":"J Biol Chem"},{"issue":"13","key":"4343_CR50","doi-asserted-by":"publisher","first-page":"e2011269118","DOI":"10.1073\/pnas.2011269118","volume":"118","author":"WF Wu","year":"2021","unstructured":"Wu WF, Wang L, Spetsieris N, Boukovala M, Efstathiou E, Brossner C, Warner M, Gustafsson JA. Estrogen receptor \u03b2 and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate. Proc Natl Acad Sci U S A. 2021;118(13):e2011269118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4343_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41389-018-0106-y","volume":"7","author":"W Wang","year":"2018","unstructured":"Wang W, Liu Y, Guo J, He H, Mi X, Chen C, Xie J, Wang S, Wu P, Cao F, Bai L. miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a\/IL-1ra pathway in mouse breast cancer. Oncogenesis. 2018;7(12):97.","journal-title":"Oncogenesis"},{"issue":"6","key":"4343_CR52","doi-asserted-by":"publisher","first-page":"e22903","DOI":"10.1002\/jcla.22903","volume":"33","author":"S Chen","year":"2019","unstructured":"Chen S, Shen Z, Liu Z, Gao L, Han Z, Yu S, Kang M. IL-1RA suppresses esophageal cancer cell growth by blocking IL-1\u03b1. J Clin Lab Anal. 2019;33(6):e22903.","journal-title":"J Clin Lab Anal"},{"key":"4343_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.30699\/ijp.2022.550727.2856","volume":"10","author":"HM El-hanbuli","year":"2022","unstructured":"El-hanbuli HM, Abou Sarie MA. KRAS protein expression in oral squamous cell carcinoma: a potential marker for progression and prognosis. Iran J Pathol. 2022;10:464\u201374.","journal-title":"Iran J Pathol"},{"key":"4343_CR54","doi-asserted-by":"publisher","first-page":"643461","DOI":"10.3389\/fgene.2021.643461","volume":"12","author":"HC Wang","year":"2021","unstructured":"Wang HC, Chiang CJ, Liu TC, Wu CC, Chen YT, Chang JG, Shieh GS. Immunohistochemical expression of five protein combinations revealed as prognostic markers in Asian oral cancer. Front Genet. 2021;12:643461.","journal-title":"Front Genet"},{"issue":"3","key":"4343_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","volume":"2","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Vander Heiden MG, McCormick F. The metabolic landscape of RAS-driven cancers from biology to therapy. Nat Cancer. 2021;2(3):271\u201383.","journal-title":"Nat Cancer"},{"issue":"8","key":"4343_CR56","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4251\/wjgo.v12.i8.877","volume":"2","author":"Y Yan","year":"2020","unstructured":"Yan Y, Lin HW, Zhuang ZN, Li M, Guo S. Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer. World J Gastrointest Oncol. 2020;2(8):877.","journal-title":"World J Gastrointest Oncol"},{"issue":"9","key":"4343_CR57","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.oraloncology.2013.06.010","volume":"49","author":"N Sinha","year":"2013","unstructured":"Sinha N, Mukhopadhyay S, Das DN, Panda PK, Bhutia SK. Relevance of cancer initiating\/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol. 2013;49(9):854\u201362.","journal-title":"Oral Oncol"},{"key":"4343_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/5584_2017_116","volume":"1083","author":"E Wolmarans","year":"2018","unstructured":"Wolmarans E, Boy SC, Nel S, Mercier AE, Pepper MS. Cancer stem cells in head and neck carcinomas: identification and possible therapeutic implications. Adv Exp Med Biol. 2018;1083:89\u2013102.","journal-title":"Adv Exp Med Biol"},{"key":"4343_CR59","doi-asserted-by":"publisher","first-page":"113860","DOI":"10.1016\/j.biopha.2022.113860","volume":"156","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, Rezaei S, Hejazi ES, Kakavand A, Heidari H, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S. SOX2 function in cancers: association with growth, invasion, stemness and therapy response. Biomed Pharmacother. 2022;156:113860.","journal-title":"Biomed Pharmacother"},{"issue":"Pt 1","key":"4343_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcancer.2020.05.007","volume":"67","author":"L Porter","year":"2020","unstructured":"Porter L, McCaughan F. SOX2 and squamous cancers. Semin Cancer Biol. 2020;67(Pt 1):154\u201367.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"4343_CR61","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/antiox10111838","volume":"10","author":"FK Choudhury","year":"2021","unstructured":"Choudhury FK. Mitochondrial redox metabolism: the epicenter of metabolism during cancer progression. Antioxidants. 2021;10(11):1838.","journal-title":"Antioxidants"},{"issue":"6","key":"4343_CR62","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation. Oncol Lett. 2012;4(6):1151\u20137.","journal-title":"Oncol Lett"},{"issue":"11","key":"4343_CR63","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3390\/antiox11112202","volume":"11","author":"C Bian","year":"2022","unstructured":"Bian C, Zheng Z, Su J, Wang H, Chang S, Xin Y, Jiang X. Targeting mitochondrial metabolism to reverse radioresistance: an alternative to glucose metabolism. Antioxidants. 2022;11(11):2202.","journal-title":"Antioxidants"},{"issue":"19","key":"4343_CR64","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.3390\/ijms221910268","volume":"22","author":"L Yan","year":"2021","unstructured":"Yan L, Tan Y, Chen G, Fan J, Zhang J. Harnessing metabolic reprogramming to improve cancer immunotherapy. Int J Mol Sci. 2021;22(19):10268.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"4343_CR65","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1002\/1873-3468.13868","volume":"594","author":"N Fisher","year":"2020","unstructured":"Fisher N, Meunier B, Biagini GA. The cytochrome bc1 complex as an antipathogenic target. FEBS Lett. 2020;594(18):2935\u201352.","journal-title":"FEBS Lett"},{"issue":"5","key":"4343_CR66","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1038\/cddis.2014.225","volume":"5","author":"MW Lee","year":"2014","unstructured":"Lee MW, Bassiouni R, Sparrow NA, Iketani A, Boohaker RJ, Moskowitz C, Vishnubhotla P, Khaled AS, Oyer J, Copik A, Fernandez-Valle C, Perez JM, Khaled AR. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption. Cell Death Dis. 2014;5(5):e1249.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4343_CR67","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","volume":"12","author":"EL Giddings","year":"2021","unstructured":"Giddings EL, Champagne DP, Wu MH, Laffin JM, Thornton TM, Valenca-Pereira F, Culp-Hill R, Fortner KA, Romero N, East J, Cao P, Arias-Pulido H, Sidhu KS, Silverstrim B, Kam Y, Kelley S, Pereira M, Bates SE, Bunn JY, Fiering SN, Matthews DE, Robey RW, Stich D, D\u2019Alessandro A, Rincon M. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nat Commun. 2021;12(1):2804.","journal-title":"Nat Commun"},{"issue":"26","key":"4343_CR68","doi-asserted-by":"publisher","first-page":"40767","DOI":"10.18632\/oncotarget.8194","volume":"7","author":"YK Chae","year":"2016","unstructured":"Chae YK, Arya A, Malecek MK, Shin DS, Carneiro B, Chandra S, Kaplan J, Kalyan A, Altman JK, Platanias L, Giles F. Repurposing metformin for cancer treatment: current clinical studies. Oncotarget. 2016;7(26):40767\u201380.","journal-title":"Oncotarget"},{"issue":"2","key":"4343_CR69","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s12032-011-9846-7","volume":"29","author":"TV Kourelis","year":"2012","unstructured":"Kourelis TV, Siegel RD. Metformin and cancer: new applications for an old drug. Med Oncol. 2012;29(2):1314\u201327.","journal-title":"Med Oncol"},{"key":"4343_CR70","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, Chandel NS. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife. 2014;3:e02242.","journal-title":"Elife"},{"issue":"1","key":"4343_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VW, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"4343_CR72","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","volume":"31","author":"JP Machiels","year":"2020","unstructured":"Machiels JP, Leemans CR, Golusinski W, Grau C, Licitra L, Gregoire V. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS\u2013ESMO\u2013ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1462\u201375.","journal-title":"Ann Oncol"},{"issue":"1","key":"4343_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cas.13849","volume":"110","author":"J Deng","year":"2019","unstructured":"Deng J, Peng M, Wang Z, Zhou S, Xiao D, Deng J, Yang X, Peng J, Yang X. Novel application of metformin combined with targeted drugs on anticancer treatment. Cancer Sci. 2019;110(1):23\u201330.","journal-title":"Cancer Sci"},{"issue":"1","key":"4343_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00280-016-3037-3","volume":"78","author":"HH Zhang","year":"2016","unstructured":"Zhang HH, Guo XL. Combinational strategies of metformin and chemotherapy in cancers. Cancer Chemother Pharmacol. 2016;78(1):13\u201326.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"4343_CR75","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1158\/0008-5472.CAN-12-4085","volume":"73","author":"CC Chang","year":"2013","unstructured":"Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MY, Lin BR, Chen ST, Tai SK, Kuo ML, Yang MH. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res. 2013;73(13):4147\u201357.","journal-title":"Cancer Res"},{"issue":"1","key":"4343_CR76","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jcb.27374","volume":"120","author":"H Chen","year":"2019","unstructured":"Chen H, Jin K, Song J, Zuo Q, Yang H, Zhang Y, Li B. Functional characterization of the Sox2, c-Myc, and Oct4 promoters. J Cell Biochem. 2019;120(1):332\u201342.","journal-title":"J Cell Biochem"},{"issue":"13","key":"4343_CR77","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1158\/0008-5472.CAN-15-2534","volume":"76","author":"G Cheng","year":"2016","unstructured":"Cheng G, Zielonka J, Ouari O, Lopez M, McAllister D, Boyle K, Barrios CS, Weber JJ, Johnson BD, Hardy M, Dwinell MB, Kalyanaraman B. Mitochondria-targeted analogues of metformin exhibit enhanced antiproliferative and radiosensitizing effects in pancreatic cancer cells. Cancer Res. 2016;76(13):3904\u201315.","journal-title":"Cancer Res"},{"key":"4343_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-022-04289-6","author":"F Zhang","year":"2023","unstructured":"Zhang F, Liu W, Long Y, Peng H. Targeted delivery of metformin against lung cancer cells via hyaluronan-modified mesoporous silica nanoparticles. Appl Biochem Biotechnol. 2023. https:\/\/doi.org\/10.1007\/s12010-022-04289-6.","journal-title":"Appl Biochem Biotechnol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04343-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04343-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04343-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T02:03:41Z","timestamp":1689559421000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04343-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4343"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04343-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2995954\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kaohsiung Medical University Hospital (approval no. KMUH-IRB-20130300 and KMUHIRB-F(I)-20220016). Patient informed consent was waived by the Institutional Review Board due to the retrospective nature of the study. All animal experiments were approved by the Institutional Animal Care and Utilization Committee of Kaohsiung Medical University, Kaohsiung, Taiwan (approval no. 108127).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"473"}}